texas oncology more breakthroughs. more victories
I am a: Patient | Caregiver | Refering Physician
Some of our cancer centers are experiencing issues.  View More Important Notifications x

San Antonio Recent Publications

Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Myelofibrosis Enrolled in the MOST Study

PUBLICATION
Clinical Lymphoma, Myeloma & Leukemia
CITATION
Clin Lymphoma Myeloma Leuk . 2022 Feb 8;S2152-2650(22)00040-4.
CLINICIANS
Aaron T. Gerds, Roger M. Lyons, Philomena Colucci, Patricia Kalafut, Dilan Paranagama, Srdan Verstovsek.
View Full Publication Here

The MD Anderson Manual of Medical Oncology, Fourth Edition

PUBLICATION
Medical Oncology, 2022
CLINICIANS
Robert Wolff, Alyssa G. Rieber
View Full Publication Here

Efficacy and Safety of Ofatumumab and Bendamustine Followed by Ofatumumab Maintenance in Patients With Relapsed Indolent Non-Hodgkin Lymphoma After Prior Rituximab

PUBLICATION
Leukemia & Lymphoma
CITATION
Leuk Lymphoma. 2021 Jun;62(6):1353-1360.
CLINICIANS
Lyons RM, Shtivelband M, Kingsley E, Moezi M, Richards D, Sharman J, Feng X, Cannan M, Fellague-Chebra R, Boyd TE.
View Full Publication Here

Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Essential Thrombocythemia Enrolled in the MOST Study

PUBLICATION
Clinical Lymphoma, Myeloma & Leukemia
CITATION
Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):461-469.
CLINICIANS
Yacoub A, Lyons R, Verstovsek S, Shao R, Chu DT, Agrawal A, Sivaraman S, Colucci P, Paranagama D, Mascarenhas J.
View Full Publication Here

Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib

PUBLICATION
Clinical Lymphoma, Myeloma & Leukemia
CITATION
Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):e910-e925
CLINICIANS
Manda S, Yimer HA, Noga SJ, Girnius S, Yasenchak CA, Charu V, Lyons R, Aiello J, Bogard K, Ferrari RH, Cherepanov D, Demers B, Lu V, Whidden P, Kambhampati S, Birhiray RE, Jhangiani HS, Boccia R, Rifkin RM.
View Full Publication Here

Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Expert Consensus Based on the RAND/UCLA Modified Delphi Panel Method

PUBLICATION
Research and Practice in Thrombosis and Haemostasis
CITATION
Res Pract Thromb Haemost. 2020 Dec 8;5(1):69-80.
CLINICIANS
Cuker A, Despotovic JM, Grace RF, Kruse C, Lambert MP, Liebman HA, Lyons RM, McCrae KR, Pullarkat V, Wasser JS, Beenhouwer D, Gibbs SN, Yermilov I, Broder MS.
View Full Publication Here

A Phase II Study of Addition of Pracinostat to a Hypomethylating Agent in Patients With Myelodysplastic Syndromes Who Have Not Responded to Previous Hypomethylating Agent Therapy

PUBLICATION
British Journal of Haematology
CITATION
Br J Haematol. 2020 Feb;188(3):404-412
CLINICIANS
Yalniz FF, Berdeja JG, Maris MB, Lyons RM, Reeves JA Jr, Essell JH, Patel P, Sekeres M, Hughes A, Mappa S, Garcia-Manero G.
View Full Publication Here
* Texas Oncology Clinicians